1. Home
  2. LFUS vs CORT Comparison

LFUS vs CORT Comparison

Compare LFUS & CORT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Littelfuse Inc.

LFUS

Littelfuse Inc.

N/A

Current Price

$414.09

Market Cap

10.4B

Sector

Energy

ML Signal

N/A

Logo Corcept Therapeutics Incorporated

CORT

Corcept Therapeutics Incorporated

N/A

Current Price

$81.72

Market Cap

9.7B

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
LFUS
CORT
Founded
1927
1998
Country
United States
United States
Employees
N/A
N/A
Industry
Electrical Products
Biotechnology: Pharmaceutical Preparations
Sector
Energy
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
10.4B
9.7B
IPO Year
1996
2001

Fundamental Metrics

Financial Performance
Metric
LFUS
CORT
Price
$414.09
$81.72
Analyst Decision
Buy
Buy
Analyst Count
4
5
Target Price
★ $496.25
$141.00
AVG Volume (30 Days)
243.0K
★ 881.3K
Earning Date
10-28-2026
11-03-2026
Dividend Yield
★ 0.81%
N/A
EPS Growth
N/A
★ N/A
EPS
★ 10.94
0.09
Revenue
$757,853,000.00
★ $761,407,000.00
Revenue This Year
$23.39
$50.42
Revenue Next Year
$11.04
$46.34
P/E Ratio
★ $36.19
$893.00
Revenue Growth
N/A
★ 12.79
52 Week Low
$233.36
$28.66
52 Week High
$500.57
$126.38

Technical Indicators

Market Signals
Indicator
LFUS
CORT
Relative Strength Index (RSI) 54.99 26.90
Support Level $389.23 $77.38
Resistance Level $428.88 $122.93
Average True Range (ATR) 18.50 5.37
MACD 3.57 -2.82
Stochastic Oscillator 93.85 8.75

Price Performance

Historical Comparison
LFUS
CORT

About LFUS Littelfuse Inc.

Littelfuse is a supplier of circuit protection products (such as fuses and relays) for the transportation, industrial, telecommunications, and consumer electronics end markets. Littelfuse also holds a minority power semiconductor business, primarily serving high-voltage industrial applications. Littelfuse sells globally across both distribution and direct channels, and organizes its business into the three segments of electronics, transportation, and industrial. Littelfuse is a serial acquirer of smaller, bolt-on adjacent firms.

About CORT Corcept Therapeutics Incorporated

Corcept Therapeutics Inc is a commercial-stage pharmaceutical company engaged in the discovery and development of medications that treat severe metabolic, oncologic, and neuropsychiatric disorders by modulating the effect of the cortisol hormone. The company markets Korlym (mifepristone) tablets and its authorized generic version, which is an oral medication for the treatment of hypercortisolism (also known as Cushing's syndrome). Additionally, its pipeline contains several key compounds, such as Relacorilant, Dazucorilant, Miricorilant, etc., that are being evaluated in clinical trials as potential treatments for a variety of serious disorders like hypercortisolism, solid tumors (including ovarian, endometrial, cervical, pancreatic, and prostate cancers), ALS, and MASH.

Share on Social Networks: